Grifols Australia Pty Ltd.
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- Subsidiary
- Employees
- -
- Market Cap
- -
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
33
TGA:33
Drug Approvals
GAMUNEX normal immunoglobulin (Human) 40g/400mL Intravenous solution vial (371434)
- Product Name
- GAMUNEX normal immunoglobulin (Human) 40g/400mL Intravenous solution vial
- Approval Date
- Sep 16, 2022
TGA
XEMBIFY normal immunoglobulin 4 g/20 mL (20%) solution for subcutaneous injection vial (380404)
- Product Name
- XEMBIFY normal immunoglobulin 4 g/20 mL (20%) solution for subcutaneous injection vial
- Approval Date
- Jun 30, 2022
TGA
XEMBIFY normal immunoglobulin 1 g/5 mL (20%) solution for subcutaneous injection vial (380405)
- Product Name
- XEMBIFY normal immunoglobulin 1 g/5 mL (20%) solution for subcutaneous injection vial
- Approval Date
- Jun 30, 2022
TGA
XEMBIFY normal immunoglobulin 2 g/10 mL (20%) solution for subcutaneous injection vial (355315)
- Product Name
- XEMBIFY normal immunoglobulin 2 g/10 mL (20%) solution for subcutaneous injection vial
- Approval Date
- Jun 30, 2022
TGA
XEMBIFY normal immunoglobulin 10 g/50 mL (20%) solution for subcutaneous injection vial (380406)
- Product Name
- XEMBIFY normal immunoglobulin 10 g/50 mL (20%) solution for subcutaneous injection vial
- Approval Date
- Jun 30, 2022
TGA
PROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 500 mg solution for injection for intravenous infusion vial (371334)
- Product Name
- PROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 500 mg solution for injection for intravenous infusion vial
- Approval Date
- May 27, 2022
TGA
PROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 4000 mg solution for injection for intravenous infusion vial (371339)
- Product Name
- PROLASTIN C LIQUID alpha-1-proteinase inhibitor (human) 4000 mg solution for injection for intravenous infusion vial
- Approval Date
- May 27, 2022
TGA
VeraSeal solutions for sealant 6 mL (Human fibrinogen 80 mg/mL syringe 3 ml / Human thrombin 500 IU/mL syringe 3 ml) (336836)
- Product Name
- VeraSeal solutions for sealant 6 mL (Human fibrinogen 80 mg/mL syringe 3 ml / Human thrombin 500 IU/mL syringe 3 ml)
- Approval Date
- Nov 3, 2021
TGA
VeraSeal solutions for sealant 10 mL (Human fibrinogen 80 mg/mL syringe 5 ml / Human thrombin 500 IU/mL syringe 5 ml) (336837)
- Product Name
- VeraSeal solutions for sealant 10 mL (Human fibrinogen 80 mg/mL syringe 5 ml / Human thrombin 500 IU/mL syringe 5 ml)
- Approval Date
- Nov 3, 2021
TGA
VeraSeal solutions for sealant 4 mL (Human fibrinogen 80 mg/mL syringe 2 ml / Human thrombin 500 IU/mL syringe 2 ml) (336835)
- Product Name
- VeraSeal solutions for sealant 4 mL (Human fibrinogen 80 mg/mL syringe 2 ml / Human thrombin 500 IU/mL syringe 2 ml)
- Approval Date
- Nov 3, 2021
TGA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found